This episode of Sue Wall Street dives deep into the class action lawsuit against Sarepta Therapeutics $SRPT. From FDA fast-tracking to tragic deaths linked to its Duchenne drug ELEVIDYS, investors are alleging massive corporate deception. If you're an investor, biotech enthusiast, or anyone tracking Wall Street accountability, this one’s for you. Expect raw details, lawsuit breakdowns, and sharp commentary.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Visit ZLK.com for more info.